← Back to headlines
Parabilis Medicines Sets Biotech IPO Record with $670 Million Offering
Parabilis Medicines has set a new record in the biotech sector by raising $670 million in its initial public offering. The company priced its upsized IPO at $19 or $20 per share, marking a significant achievement in the industry.
10 Jun, 06:52 — 10 Jun, 06:52
Sources
Showing 1 of 2 sources
Coverage Timeline
First report: seeking-alpha · 10 Jun, 06:52|Full coverage: 2 · 9h|Window: 9h
Left-leaningCenterRight-leaning
Related Stories
Invisible AI Watermarks Deployed to Identify AI-Generated Text, Including in Academic Settings
2h ago
Meta and TikTok Agree to Combat Disinformation After Ceuta Migrant Crisis
2h ago
Solar Eclipse Poses Challenge for European Solar Farms
3h ago
Vietnam's VinSpace Partners with SpaceX for First Satellite Launch
3h ago